Back to search
FDAFDA · Food and drugs·Recall number D-0201-2025

Clobazam Tablets, 10 mg, packaged in 30 tablets per carton (3x10 blister cards each), Rx Only, Amneal Pharmaceuticals LLC, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 60687-423-11

Published January 22, 2025 · Recall initiated: January 7, 2025

Summary

FDA records drug Class II recall D-0201-2025, published January 22, 2025 and initiated January 7, 2025. Recalling firm: Amerisource Health Services LLC; Status: Ongoing; Reported quantity: 4640 units; Lot: Lot #: 1018598, Exp. Date 10/31/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Tablets/Capsules

What to do

Voluntary: Firm initiated

Get an email if CLOBAZAM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CLOBAZAM
Manufacturer
Amerisource Health Services LLC
Distributor
Nationwide within the United States
Lot
Lot #: 1018598, Exp. Date 10/31/2025
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Clobazam Tablets, 10 mg, packaged in 30 tablets per carton (3x10 blister cards each), Rx Only, Amneal Pharmaceuticals LLC, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 60687-423-11 recalled?

Yes. FDA published recall D-0201-2025 on January 22, 2025. Reported hazard: Presence of Foreign Tablets/Capsules

What should I do if I have this product?

Voluntary: Firm initiated

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CLOBAZAM.